Adenocarcinoma in situ of the cervix:: Management and outcome

被引:75
|
作者
Azodi, M [1 ]
Chambers, SK [1 ]
Rutherford, TJ [1 ]
Kohorn, EI [1 ]
Schwartz, PE [1 ]
Chambers, JT [1 ]
机构
[1] Yale Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, New Haven, CT 06520 USA
关键词
D O I
10.1006/gyno.1999.5395
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The aim of this study was to review the management and outcome of patients with adenocarcinoma in situ of the cenix and to evaluate the significance of endocervical cone margin status in these patients. Methods. A retrospective review of records between January 1988 and December 1996 identified 40 patients with adenocarcinoma in situ on cone biopsy for whom complete information was available. The median follow-up was 38 months. Results. The mean age was 37 years, and the mean parity was 1.3. Fifty-three percent of the patients had prior abnormal cervical cytology. The initial Pap smear that led to the patient's referral was abnormal in 39 (98%). Initial cervical biopsies showed adenocarcinoma in situ and/or glandular dysplasia in 28 (70%), squamous dysplasia in 2 (5%), chronic inflammation in 2 (5%), and no pathologic changes in 2 (5%) patients. Initially no biopsies were performed in 3 (7.5%) patients and the results of 3 (7.5%) biopsies were unknown. Subsequently, all patients had cone biopsies. The endocervical margins were positive for glandular abnormalities in 24% of cold knife cones (CKC), 75% of LEEPs, and 57% of laser cones. The ectocervical margins were positive for squamous and/or glandular abnormalities in 8% of CKCs, 13% of LEEPs, and 57% of laser cones. ECCs above the cone were obtained in 28 patients, and only 1 (3%) was positive. The definitive treatment was hysterectomy in 27, repeat cone in 5, and no additional therapy in 8 patients. The pathology showed residual disease in 44% of treated patients. From 16 cone biopsies with negative margins who had subsequent treatment, there was residual disease in 5 (31%) specimens (1 adenocarcinoma in situ, 1 mild glandular dysplasia, 3 glandular atypia). From 16 cones with positive margins who had subsequent treatment, there was residual disease in 9 (56%) specimens. The patients with negative ECCs above the cone regardless of margin status had residual disease in 58% of treated specimens. Conclusion. Women with adenocarcinoma in situ of the uterine cenix had residual disease in 31% of cases with negative margins in cone biopsies and/or with negative ECCs and in 56% of cases with positive endocervical margins. LEEP cones had higher rate of positive endocervical margins (75%) compared to CKC (24%) and laser cone (57%). If maintaining reproductive capacity is desired, we would recommend CKC; however, this does not guarantee absence of the disease. (C) 1999 Academic Press.
引用
收藏
页码:348 / 353
页数:6
相关论文
共 50 条
  • [1] Adenocarcinoma in situ of the uterine cervix: Management and outcome
    Widrich, T
    Kennedy, AW
    Myers, TM
    Hart, WR
    Wirth, S
    GYNECOLOGIC ONCOLOGY, 1996, 61 (03) : 304 - 308
  • [2] Management of adenocarcinoma in situ of the cervix
    Powell, JL
    GYNECOLOGIC ONCOLOGY, 1999, 75 (03) : 520 - 521
  • [3] Conservative management of adenocarcinoma in situ of the cervix
    Shin, CH
    Schorge, JO
    Lee, KR
    Sheets, EE
    GYNECOLOGIC ONCOLOGY, 2000, 79 (01) : 6 - 10
  • [4] Cold knife versus laser cone biopsy for adenocarcinoma in situ of the cervix -: a comparison of management and outcome
    Dalrymple, C.
    Valmadre, S.
    Cook, A.
    Atkinson, K.
    Carter, J.
    Houghton, C. R. S.
    Russell, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (01) : 116 - 120
  • [5] The safety of conization in the management of adenocarcinoma in situ of the uterine cervix
    Kim, Mi-La
    Hahn, Ho-Suap
    Lim, Kyung-Taek
    Lee, Ki-Heon
    Kim, Hy-Sook
    Hong, Sung-Ran
    Kim, Tae-Jin
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2011, 22 (01) : 25 - 31
  • [6] Management of adenocarcinoma in situ, micro-invasive, and early stage adenocarcinoma of the cervix
    Sheets, EE
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2002, 14 (01) : 53 - 57
  • [7] Is loop excision adequate primary management of adenocarcinoma in situ of the cervix?
    Houghton, SJ
    Shafi, MI
    Rollason, TP
    Luesley, DM
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (03): : 325 - 329
  • [8] Villoglandular adenocarcinoma of cervix: pathologic features, clinical management, and outcome
    Guo, Peng
    Liu, Pengfei
    Yang, Junjun
    Ren, Tong
    Xiang, Yang
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 3955 - 3961
  • [9] Adenocarcinoma in situ of the cervix in pregnancy
    Griffin, D
    Manuck, TA
    Hoffman, MS
    GYNECOLOGIC ONCOLOGY, 2005, 97 (02) : 662 - 664
  • [10] Colposcopy of adenocarcinoma in situ and adenocarcinoma of the uterine cervix
    Wright, C
    EUROGIN 2000: 4TH INTERNATIONAL MULTIDISCIPLINARY CONGRESS, 2000, : 87 - 93